While rhinoviruses and seasonal colds are already circulating widely, pediatric experts are warning that a wave of Respiratory Syncytial Virus (RSV) is approaching, albeit on a slightly different timeline than in recent years. In North Rhine-Westphalia, Germany, clinicians report that the typical RSV season appears to be delayed, offering a crucial window for preventative measures in vulnerable infants.
Key Observations
- Delayed Onset: Current infection rates are lower than those seen in previous Novembers, but cases are expected to rise significantly in late November and early December.
- High-Risk Groups: While most children contract RSV by age two, severe courses are most common in infants under six months, premature babies, and children with underlying health conditions.
- Vaccination Window: The delayed peak provides additional time for parents to immunize infants and for pregnant individuals to receive vaccinations that protect newborns.
A Shift in Seasonality
RSV, a globally prevalent pathogen causing acute respiratory diseases, typically circulates in the Northern Hemisphere between October and March. However, pediatric pulmonologists are noting distinct patterns this season. Professor Dr. Dominik Schneider, Director of the Clinic for Child and Adolescent Medicine at Dortmund Hospital, noted that the current burden is lighter compared to previous years.
At this point in time, it is less severe than in previous years in November. But now comes the phase where we will be in closed rooms more often—infections will significantly increase.
Prof. Dr. Dominik Schneider, Pediatric Clinic Director
This slower start creates a strategic advantage for healthcare providers and families. I have the impression that this year will be rather a late RSV season,
Prof. Schneider stated, adding that the delay naturally gives us a lot of time to vaccinate small infants now.
Recognizing Severe Symptoms
For older children and healthy adults, RSV typically presents as a mild upper respiratory infection with cold-like symptoms. However, for infants and older adults (particularly those over 75 or with comorbidities), the virus can migrate to the lower respiratory tract, causing bronchiolitis or pneumonia.
In severe cases necessitating hospitalization, infants may display distressing respiratory signs. Prof. Schneider described the clinical presentation in colonized infants vividly:
The children cannot drink, they have fever and cough, and it is a truly pitiful, whistling, wheezing cough… The children have severe shortness of breath.
He further noted that some infants may require hospitalization for up to ten days to manage respiratory distress, describing it as a nasty infection that makes children really sick
and observing that recovered children often remain sensitive to subsequent respiratory infections.
Clinical Signs to Watch
Pediatric guidelines highlight strict monitoring for the following progression of symptoms:
- Initial symptoms: Cough, runny nose, and mild fever.
- Lower respiratory involvement: Wheezing (a whistling sound when breathing out), rapid breathing, and persistent cough.
- Severe distress: Gasping for air, pauses in breathing (apnea), and inability to feed due to respiratory effort.
Preventative Measures
Medical experts emphasize that while older children and adults often experience RSV as a recurring, manageable winter virus—something that belongs to every winter,
according to Prof. Schneider—they play a key role in transmission. The virus spreads via droplets and contaminated surfaces.
To protect high-risk infants, health authorities recommend a combination of immunization and hygiene protocols:
- Immunization: Passive immunization for infants is available and recommended, particularly for those in their first RSV season. Additionally, vaccination during pregnancy allows antibodies to be transferred to the fetus via the placenta. Prof. Schneider termed this maternal protection
comparably good.
- Hygiene: Regular hand washing and the disinfection of shared objects, such as toys and bottles, are critical.
- Contact limitation: Restricting contact between vulnerable infants and individuals showing signs of symptomatic respiratory illness limits exposure.
